STARLIMS Announces Shareholder Approval of Acquisition by Abbott

STARLIMS Technologies Ltd. (Nasdaq:LIMS ), a leading provider of laboratory information management systems (LIMS), today announced that at its special meeting of shareholders held today, STARLIMS's shareholders approved the terms and conditions of the previously announced acquisition of STARLIMS by Abbott (NYSE:ABT), the global health care company.

The transaction is subject to customary closing conditions. Under Israeli law, at least 30 days must have elapsed after the approval of the acquisition by the shareholders of STARLIMS before the acquisition may become effective. STARLIMS and Abbott expect to complete the transaction by March 31, 2010. 

About STARLIMS

STARLIMS Technologies Ltd. (Nasdaq:LIMS) is a leading provider of laboratory information management systems (LIMS), with over 20 years of LIMS experience. The Company's flagship product, STARLIMS®, improves the reliability of laboratory sampling processes, supports compliance with domestic and international regulations and industry standards, and provides comprehensive reporting, monitoring and analysis capabilities. STARLIMS software is used for quality assurance and control, testing and monitoring, and research and development in government, manufacturing and life sciences organizations. With operations in the United States, Canada, the United Kingdom, Israel and Hong Kong, the company serves over 500 organizations in 40 countries. For more information, please see http://www.starlims.com.

Safe Harbor for Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties which could cause the actual results, performance or achievements of the company to be materially different from those which may be expressed or implied by such statements, including, among others, changes in general economic and business conditions, changes in demand for products and services, the timing and amount or cancellation of orders, loss of market share and other risks detailed from time to time in STARLIMS's filings from time to time with the Securities and Exchange Commission. Such filings contain and identify these and other important factors that could cause actual results to differ materially from those contained in our projections or forward-looking statements. Shareholders and other readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. We undertake no obligation to update publicly or revise any forward-looking statement.

CONTACT:  STARLIMS Technologies Ltd.

          Tamar Harris, Director of Corporate Communications
          [phone]
          [e-mail]
          Integrated Corporate Relations (ICR)
          Investor Relations:
          Kori Doherty
          [phone]
          [e-mail]